DJ AbbVie Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. $(ABBV)$ slipped 1.12% to $263.29 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.17% to 7,670.84 and Dow Jones Industrial Average falling 0.26% to 51,349.92.
AbbVie Inc. closed 2.26% short of its 52-week high of $269.39, which the company reached on September 23rd.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 1.61% to $267.57, Pfizer Inc. $(PFE)$ remained unchanged, and Amgen Inc. $(AMGN)$ rose 1.32% to $423.64.
Trading volume (3.9 M) remained 775,865 below its 50-day average volume of 4.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 29, 2026.